Leucine Aminopeptidase Determination Reagent Kit (L-Leucine-p-Nitroaniline Substrate Method) - NMPA Registration 冀械注准20142400342
Access comprehensive regulatory information for Leucine Aminopeptidase Determination Reagent Kit (L-Leucine-p-Nitroaniline Substrate Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 冀械注准20142400342 and owned by Langfang Hengyi Biotechnology Co., Ltd.. The device was approved on November 07, 2019.
This page provides complete registration details including registrant information, province location (Hebei), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
For in vitro quantitative determination of leucine aminopeptidase activity in serum.
用于体外定量测定血清中亮氨酸氨基肽酶的活性。
Reagent 1: Trihydroxyaminomethane-hydrochloric acid (Tris-HCl), 100mmol/L; Reagent 2: L-Leucyl-p-nitroaniline, 10 mmol/L.
试剂1：三羟基氨基甲烷-盐酸（Tris-HCl），100mmol/L；试剂2：L-亮氨酰对硝基苯胺，10mmol/L。